APA

Nakazaki K., Kato Y., Taguchi T., Inayama Y., Ishiguro Y., Kondo N., Horiuchi C., Sakakibara A. & Tsukuda M. (2010). Heterozygous mutation (G/G→G/A) at nt 2607 of the EGFR gene is closely associated with increases in EGFR copy number and mRNA half life, but impaired EGFR protein synthesis in squamous cell carcinomas of the head and neck - implication for gefitinib efficacy. : Oncology letters.

Chicago

Nakazaki Kouichi, Kato Yasumasa, Taguchi Takahide, Inayama Yoshizaki, Ishiguro Yukari, Kondo Norio, Horiuchi Chouichi, Sakakibara Atuko and Tsukuda Mamoru. 2010. Heterozygous mutation (G/G→G/A) at nt 2607 of the EGFR gene is closely associated with increases in EGFR copy number and mRNA half life, but impaired EGFR protein synthesis in squamous cell carcinomas of the head and neck - implication for gefitinib efficacy. : Oncology letters.

Harvard

Nakazaki K., Kato Y., Taguchi T., Inayama Y., Ishiguro Y., Kondo N., Horiuchi C., Sakakibara A. and Tsukuda M. (2010). Heterozygous mutation (G/G→G/A) at nt 2607 of the EGFR gene is closely associated with increases in EGFR copy number and mRNA half life, but impaired EGFR protein synthesis in squamous cell carcinomas of the head and neck - implication for gefitinib efficacy. : Oncology letters.

MLA

Nakazaki Kouichi, Kato Yasumasa, Taguchi Takahide, Inayama Yoshizaki, Ishiguro Yukari, Kondo Norio, Horiuchi Chouichi, Sakakibara Atuko and Tsukuda Mamoru. Heterozygous mutation (G/G→G/A) at nt 2607 of the EGFR gene is closely associated with increases in EGFR copy number and mRNA half life, but impaired EGFR protein synthesis in squamous cell carcinomas of the head and neck - implication for gefitinib efficacy. : Oncology letters. 2010.